Haemonetics reported $1.11B in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
Baxter International USD 8.62B 6M Jun/2026
Becton, Dickinson and Co. USD 13.42B 89M Sep/2026
Boston Scientific USD 10.79B 73M Jun/2026
Cerus USD 64.86M 22K Dec/2024
Cooper Companies USD 1.92B 54.8M Jun/2026
Fresenius EUR 10.51B 952M Sep/2026
Fresenius Medical Care EUR 5.15B 676.78M Sep/2026
Globus Medical USD 326K 54K Sep/2026
Haemonetics USD 1.11B 55.08M Sep/2026
ICU Medical USD 1.13B 79.35M Sep/2026
Intuitive Surgical USD 0 0 Mar/2025
Medtronic USD 25.62B 502M Jun/2026
Merit Medical Systems USD 737.4M 1.15M Sep/2026
Neogen USD 774.2M 19.5M Jun/2026
OraSure Technologies USD 100K 17K Dec/2025
Plus Therapeutics USD 3.79M 322K Dec/2022
Quidel USD 2.51B 22.5M Sep/2026
ResMed USD 399.42M 4.75M Jun/2026
STAAR Surgical USD 42K 42K Dec/2023
Steris USD 1.65B 100K Sep/2026
Stryker USD 14.18B 16M Sep/2026
Teleflex USD 1.53B 1.19B Sep/2026
Terumo JPY 246.97B 37.45B Sep/2026
Thermo Fisher Scientific USD 39.11B 73M Sep/2026
US Physical Therapy USD 241.69M 26.23M Sep/2026
Zimmer Biomet Holdings USD 6.22B 61M Sep/2026